Insights

Loading spinner
Gathering insights about XOStem, Inc

XOStem, Inc Tech Stack

XOStem, Inc uses 8 technology products and services including Varnish, Amazon Web Services, Open Graph, and more. Explore XOStem, Inc's tech stack below.

  • Varnish
    Caching
  • Amazon Web Services
    Cloud Hosting
  • Open Graph
    Content Management System
  • Google Fonts API
    Font Scripts
  • Webflow
    Page Builders
  • Lua
    Programming Languages
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

XOStem, Inc's Email Address Formats

XOStem, Inc uses at least 1 format(s):
XOStem, Inc Email FormatsExamplePercentage
First@xostem.comJohn@xostem.com
50%
First@xostem.comJohn@xostem.com
50%

Frequently Asked Questions

Where is XOStem, Inc's headquarters located?

Minus sign iconPlus sign icon
XOStem, Inc's main headquarters is located at 17252 Armstrong Avenue Suite a Irvine, California 92614 United States. The company has employees across 1 continents, including North America.

What is XOStem, Inc's official website and social media links?

Minus sign iconPlus sign icon
XOStem, Inc's official website is xostem.com and has social profiles on LinkedInCrunchbase.

What is XOStem, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
XOStem, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XOStem, Inc have currently?

Minus sign iconPlus sign icon
As of February 2026, XOStem, Inc has approximately 4 employees across 1 continents, including North America. Key team members include Founder & Ceo: J. S.Research Technician: A. B.. Explore XOStem, Inc's employee directory with LeadIQ.

What industry does XOStem, Inc belong to?

Minus sign iconPlus sign icon
XOStem, Inc operates in the Biotechnology Research industry.

What technology does XOStem, Inc use?

Minus sign iconPlus sign icon
XOStem, Inc's tech stack includes VarnishAmazon Web ServicesOpen GraphGoogle Fonts APIWebflowLuaOpenRestyNginx.

What is XOStem, Inc's email format?

Minus sign iconPlus sign icon
XOStem, Inc's email format typically follows the pattern of First@xostem.com. Find more XOStem, Inc email formats with LeadIQ.

How much funding has XOStem, Inc raised to date?

Minus sign iconPlus sign icon
As of February 2026, XOStem, Inc has raised $303K in funding. The last funding round occurred on Jun 01, 2020 for $303K.

When was XOStem, Inc founded?

Minus sign iconPlus sign icon
XOStem, Inc was founded in 2018.

XOStem, Inc

Biotechnology ResearchCalifornia, United States2-10 Employees

XOStem is on the leading edge of translational biochemistry, using our Stem Cell expertise to create the next generation treatment for Type 1 Diabetes and produce Engineered Exosomes. Our combination of commercially developed science, partnerships with key scientific institutions, and university validation, enables us to rapidly bring to market novel therapies to tangibly improve people’s lives. More applications utilizing our Stem Cell technology will follow.

Our engineered exosome science is bringing to market the next generation of exosomes for regenerative skin care, joint care, and other therapies. Our research, technology and assays encompass the best methods for exosome isolation, purity, and characterization. More importantly our science leads the new frontier of engineered exosomes that carry well-defined payloads for more successful outcomes.

Our bioscience device will contain insulin producing cells similar to islets found in a healthy pancreas. Our unique encapsulation technology protects our cells from the autoimmune attack that killed the islets in the patient’s pancreas. Our device eliminates the pricking, needles, sensors and ports used by traditional insulin injection.

Existing therapies for type 1 diabetes patients inject insulin using manual or automated methods, attempting to emulate pancreatic islet production of insulin. While better methods for monitoring and injection have been attempted, many drawbacks exist, and none control blood sugar levels to the tight level of natural islets. More importantly, the micro encapsulated islets combined with our macro device will control blood sugar levels to the same levels of a normal pancreas, minimizing the likelihood of the dreaded diabetes complications.

Our team has decades of experience refining our technology in the laboratory, we are now moving to alleviate type 1 diabetes in companion animals (Dogs and Cats), once our process has significant successful data, we will then move to humans.

Section iconCompany Overview

Headquarters
17252 Armstrong Avenue Suite a Irvine, California 92614 United States
Website
xostem.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $303K

    XOStem, Inc has raised a total of $303K of funding over 1 rounds. Their latest funding round was raised on Jun 01, 2020 in the amount of $303K.

  • $1M$10M

    XOStem, Inc's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $303K

    XOStem, Inc has raised a total of $303K of funding over 1 rounds. Their latest funding round was raised on Jun 01, 2020 in the amount of $303K.

  • $1M$10M

    XOStem, Inc's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.